{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:12:00Z","timestamp":1790863920773,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2351,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.bbmt.2008.08.012","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T09:00:59Z","timestamp":1224320459000},"page":"1262-1269","source":"Crossref","is-referenced-by-count":26,"title":["Autologous Stem Cell Transplantation with PCR-Negative Graft Would Be Associated with a Favorable Outcome in Core-Binding Factor Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"14","author":[{"given":"Hideki","family":"Nakasone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Muramatsu-Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Usuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.08.012_bib1","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199409049690","article-title":"The AML1 and ETO genes in acute myeloid leukemia with a t(8;21)","volume":"14","author":"Nucifora","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2008.08.012_bib3","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib4","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.leu.2404905","article-title":"Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan","volume":"22","author":"Narimatsu","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.08.012_bib6","first-page":"4173","article-title":"Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype","volume":"58","author":"Bloomfield","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2008.08.012_bib7","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1200\/JCO.1999.17.12.3767","article-title":"Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered","volume":"17","author":"Byrd","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib8","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1200\/JCO.2004.03.012","article-title":"Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup","volume":"22","author":"Schlenk","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib9","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2005.15.610","article-title":"Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study","volume":"23","author":"Marcucci","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib10","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1182\/blood.V99.10.3517","article-title":"A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup","volume":"99","author":"Nguyen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood.V90.4.1643","article-title":"Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"90","author":"Baer","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib13","first-page":"699","article-title":"Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta\/MYH11 rearrangement","volume":"85","author":"Mart\u00edn","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2008.08.012_bib14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/sj.leu.2403009","article-title":"Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial","volume":"17","author":"Schlenk","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.08.012_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood-2002-11-3527","article-title":"Prognosis of inv(16)\/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup","volume":"102","author":"Delaunay","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib16","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood.V80.7.1825.1825","article-title":"Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1\/ETO, with similarity to Drosophila segmentation gene, runt","volume":"80","author":"Erickson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bmt.1703535","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe","volume":"29","author":"Urbano-Ispizua","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.012_bib19","unstructured":"Indication guideline of hematopoietic stem cell transplantation. The Japan Society of Hematopoietic Cell Transplantation. http:\/\/www.jshct.com\/guideline\/pdf\/2002.pdf"},{"key":"10.1016\/j.bbmt.2008.08.012_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1700979","article-title":"Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia","volume":"20","author":"Gondo","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.012_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.1999.01674.x","article-title":"Real-time RT-PCR for the detection and quantification of AML1\/MTG8 fusion transcripts in t(8;21)-positive AML patients","volume":"107","author":"Krauter","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib22","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood.V83.7.1750.1750","article-title":"Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia","volume":"83","author":"Claxton","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood.V85.5.1313.bloodjournal8551313","article-title":"Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias","volume":"85","author":"Poirel","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib24","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1701920","article-title":"Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells","volume":"24","author":"Visani","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.012_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3324\/haematol.10552","article-title":"Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study","volume":"92","author":"Thomas","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2008.08.012_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.1995.tb05258.x","article-title":"Quantitative analysis of AML1\/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia","volume":"91","author":"Miyamoto","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.08.012_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.leu.2401435","article-title":"Analysis of CD34 populations in mobilised peripheral blood stem cell harvests and in bone marrow by fluorescent in situ hybridisation for the bcr\/abl gene fusion in patients with chronic granulocytic leukaemia","volume":"13","author":"Irving","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.08.012_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bmt.1700906","article-title":"G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia","volume":"20","author":"Clutterbuck","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.012_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","article-title":"Gene-marking to trace origin of relapse after autologous bone-marrow transplantation","volume":"341","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2008.08.012_bib31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1701491","article-title":"Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods","volume":"22","author":"Testoni","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.08.012_bib32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood.V88.6.2183.bloodjournal8862183","article-title":"Persistence of the AML1\/ETO fusion transcript in patients treated with allogeneic transplantation for t(8;21) leukemia","volume":"88","author":"Jurlander","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib33","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1182\/blood.V87.11.4789.bloodjournal87114789","article-title":"Persistence of multipotent progenitors expressing AML1\/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia","volume":"87","author":"Miyamoto","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.08.012_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.leu.2402478","article-title":"Assessment of minimal residual disease (MRD) in CBFbeta\/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts","volume":"16","author":"Guerrasio","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.08.012_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/10428190310001638913","article-title":"Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center study","volume":"45","author":"Mitterbauer","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2008.08.012_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.leu.2404015","article-title":"Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]","volume":"20","author":"Perea","year":"2006","journal-title":"Leukemia"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108003790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108003790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:30:59Z","timestamp":1589027459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108003790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1083879108003790"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.08.012","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}